Results 111 to 120 of about 52,421 (257)
Our study found that the neutrophil‐to‐lymphocyte ratio elevation in the early phase after immune checkpoint inhibitors (ICIs) treatment in non‐small‐cell lung cancer is a predictive factor for ICI‐related myocarditis. Regular and frequent cardiac monitoring may help to avoid the occurrence of severe and fatal cases.
Jian Xue+6 more
wiley +1 more source
Wolff‐Parkinson‐White Mimicking Posterior STEMI: When Even AI Gets It Wrong
ABSTRACT Wolff‐Parkinson‐White (WPW) can mimic ischemic ECG patterns, leading to potential misdiagnosis of acute coronary syndromes. This case highlights the importance of integrating clinical evaluation, echocardiography, and troponin testing with AI‐assisted ECG analysis to accurately differentiate pre‐excitation from true ischemia and avoid ...
Marco Biasin+3 more
wiley +1 more source
A SUGGESTION FOR A METHOD OF OPENING THE PERICARDIAL SAC, FOUNDED UPON A CASE OF PURULENT PERICARDITIS. [PDF]
Cyril Ogle, Herbert Allingham
openalex +1 more source
ABSTRACT Hemophagocytic lymphohistiocytosis (HLH) is a rare and potentially fatal clinical and histological entity. Macrophage Activation Syndrome (MAS) is an HLH secondary to rheumatic and autoimmune diseases. Secondary MAS in systemic lupus erythematosus (SLE) is underdiagnosed. Its treatment is not yet standardized.
L. N. Rakotonirina+5 more
wiley +1 more source
Tuberculosis pericarditis as a potentially fatal complication of tuberculosis requires effective diagnosis and treatment. We evaluated the efficacy of interferon-gamma (IFN-gamma) and adenosine deaminase (ADA) for diagnosing tuberculosis pericarditis in ...
Hamid Emadi Koochak+8 more
doaj
Absence of Abdominal Respiratory Movement as an Indication of Pericarditis [PDF]
W. Essex Wynter
openalex +1 more source
Hayden, Brogan, Prahlow, Joseph A.
openaire +3 more sources
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli+17 more
wiley +1 more source